Listen: JPM2024 Day 2 Highlights
The BioSpace team is recording from San Francisco as they bring you the the latest highlights from Day 2 at JPM2024.
Uncategorized
AI, Neuroscience and GLP-1s Will Maintain Momentum: Expert Panel
As the second day of the 42nd J.P. Morgan Healthcare Conference dawned in San Francisco, experts from Boston Consulting Group, Merck, CVC and more provided their outlook on the year ahead.
AI, Neuroscience and GLP-1s Will Maintain Momentum: Expert Panel Read More »
Mortality rates low for hospital-at-home patients, study finds
The study could support extending acute hospital care at home, researchers said. Currently, a pandemic-era waiver for the programs is set to expire at the end of the year.
Mortality rates low for hospital-at-home patients, study finds Read More »
J&J’s Megadyne restricts use of electrodes over burn risk, triggering Class I FDA notice
The J&J unit limited the use of the product in children after receiving reports of burn injuries that could be particularly harmful to them.
J&J’s Megadyne restricts use of electrodes over burn risk, triggering Class I FDA notice Read More »
Medtronic focused on delivering durable revenue and profit growth
“Our top priority is restoring our earnings power, full stop,” CEO Geoff Martha said Monday at the J.P. Morgan Healthcare Conference.
Medtronic focused on delivering durable revenue and profit growth Read More »
Most nonprofit hospitals and health systems had ‘strong’ cash reserves in 2022, KFF finds
An analysis of cash on hand suggests that, despite declining operating margins, some nonprofit health systems had enough of a financial cushion to weather tough operating conditions in 2022.
Walgreens to pay Humana $360M to settle drug pricing dispute
The settlement is a little over half of what Walgreens was originally ordered to pay, after an arbiter said the retail pharmacy chain overcharged Humana for prescription drugs for more than a decade.
Walgreens to pay Humana $360M to settle drug pricing dispute Read More »
5 medtech trends to watch in 2024
From the M&A outlook and tough year-over-year comparisons to emerging markets like pulsed field ablation, here are the top medical technology trends to watch this year.
Dexcom plans to launch new CGM this summer for people who don’t take insulin
The company also shared earnings expectations for 2024 at the J.P. Morgan Healthcare Conference.
Dexcom plans to launch new CGM this summer for people who don’t take insulin Read More »
Digital health funding reached lowest level since 2019 last year: report
Startups turned to “creative” funding mechanisms like unlabeled and silent rounds to buy time in 2023, but those strategies likely won’t work again this year, according to a report by Rock Health.
Digital health funding reached lowest level since 2019 last year: report Read More »